2-43886551-A-AC
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_133259.4(LRPPRC):c.*2048dupG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00287 in 151,678 control chromosomes in the GnomAD database, including 4 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0029 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
LRPPRC
NM_133259.4 3_prime_UTR
NM_133259.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.03
Genes affected
LRPPRC (HGNC:15714): (leucine rich pentatricopeptide repeat containing) This gene encodes a leucine-rich protein that has multiple pentatricopeptide repeats (PPR). The precise role of this protein is unknown but studies suggest it may play a role in cytoskeletal organization, vesicular transport, or in transcriptional regulation of both nuclear and mitochondrial genes. The protein localizes primarily to mitochondria and is predicted to have an N-terminal mitochondrial targeting sequence. Mutations in this gene are associated with the French-Canadian type of Leigh syndrome. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00287 (436/151678) while in subpopulation NFE AF= 0.00451 (306/67868). AF 95% confidence interval is 0.00409. There are 4 homozygotes in gnomad4. There are 182 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRPPRC | NM_133259.4 | c.*2048dupG | 3_prime_UTR_variant | 38/38 | ENST00000260665.12 | NP_573566.2 | ||
LRPPRC | XM_006711915.3 | c.*2048dupG | 3_prime_UTR_variant | 38/38 | XP_006711978.1 | |||
LRPPRC | XM_047442809.1 | c.*2048dupG | 3_prime_UTR_variant | 38/38 | XP_047298765.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRPPRC | ENST00000260665 | c.*2048dupG | 3_prime_UTR_variant | 38/38 | 1 | NM_133259.4 | ENSP00000260665.7 | |||
LRPPRC | ENST00000682612.1 | n.*2200dupG | non_coding_transcript_exon_variant | 8/8 | ENSP00000507966.1 | |||||
LRPPRC | ENST00000684454.1 | n.10097dupG | non_coding_transcript_exon_variant | 7/7 | ||||||
LRPPRC | ENST00000682612.1 | n.*2200dupG | 3_prime_UTR_variant | 8/8 | ENSP00000507966.1 |
Frequencies
GnomAD3 genomes AF: 0.00287 AC: 435AN: 151560Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
435
AN:
151560
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 10Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 6
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
10
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
6
Gnomad4 AFR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.00287 AC: 436AN: 151678Hom.: 4 Cov.: 32 AF XY: 0.00246 AC XY: 182AN XY: 74108
GnomAD4 genome
AF:
AC:
436
AN:
151678
Hom.:
Cov.:
32
AF XY:
AC XY:
182
AN XY:
74108
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Leigh syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at